Research programme: Inflammatory diseases therapeutics - Gilead Sciences
Alternative Names: Research programme: Innate immunity inhibitors - Gilead Sciences; Research programme: Innate immunity-targeted therapeutics - Gilead SciencesLatest Information Update: 17 Jun 2021
At a glance
- Originator Gilead Sciences
- Class Anti-inflammatories; Small molecules
- Mechanism of Action Neutrophil modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Inflammation